HeartWare vote for US move

By Dylan Bushell-Embling
Wednesday, 17 September, 2008

Medical device company HeartWare [ASX: HTW] has received federal court approval to go ahead with shareholder meetings to vote on its plans to redomicile in the US.

Meetings are planned for October 22.

HeartWare has appointed BDO Kendalls Corporate Finance (QLD) to independently assess the proposed scheme. BDO has determined that the scheme is in the best interest of all stockholders.

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...

Free meningococcal B vaccines coming to the NT

The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...

Mouth bacteria linked to increased head and neck cancer risk

More than a dozen bacterial species that live in people's mouths have been linked to a...

Content from other channels on our network

Custom Denning achieves first pantograph fast-charging electric bus

Orica cuts particle emissions from Kooragang Island site by 95%

Air-gapped networks give a false sense of security

BHP strengthens partnership with ABB

Seamless modular I/O integration

Burnet, Atomo to jointly develop active syphilis self-test

My Health Record: ADHA seeks industry input on support, maintenance

Monash, Optiscan partner to develop AI-powered endoscopes

Review proposes major health system changes

Private Health CEO Forum to tackle financial viability issues

SA project uses Cement Australia's low-carbon tech

Data centres working to use water responsibly

Orica cuts particle emissions from Kooragang Island site by around 95%

CSIRO's new facility for printed flexible solar techology

Driving change: how electric vehicles are fuelling Australia's sustainable businesses